This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
<ArtifactAssessment xmlns="http://hl7.org/fhir">
<id value="179694"/>
<meta>
<versionId value="3"/>
<lastUpdated value="2023-12-04T21:36:46.302Z"/>
<profile value="http://hl7.org/fhir/uv/ebm/StructureDefinition/comment"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: ArtifactAssessment</b><a name="179694"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ArtifactAssessment "179694" Version "3" Updated "2023-12-04 21:36:46+0000" </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-comment.html">Comment</a></p></div><p><b>Artifact URL</b>: <a href="https://fevir.net/resources/ArtifactAssessment/179694">https://fevir.net/resources/ArtifactAssessment/179694</a></p><p><b>Artifact Description</b>: This example of a Comment Profile shows a comment about another Resource (Guideline Profile) in which the commenter is not the author of the Resource commented upon.</p><p><b>Artifact Author</b>: Joanne Dehnbostel: </p><blockquote><p><b>modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]</b></p></blockquote><p><b>identifier</b>: FEvIR Object Identifier: 179694</p><p><b>title</b>: Comment on Guideline: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes by Joanne Dehnbostel 2023-11-28T15:19:01.266Z</p><p><b>citeAs</b>: Comment on Guideline: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes by Joanne Dehnbostel 2023-11-28T15:19:01.266Z [ArtifactAssessment]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179694. Revised 2023-11-28. Available at: https://fevir.net/resources/ArtifactAssessment/179694. Computable resource at: https://fevir.net/resources/ArtifactAssessment/179694.</p><p><b>artifact</b>: <a href="Composition-179465.html">Composition/179465: Guideline: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes</a></p><h3>Contents</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Summary</b></td><td><b>FreeToShare</b></td></tr><tr><td style="display: none">*</td><td>It is not clear whether the reference to Asian Americans includes native Hawaiians or Pacific Islanders.</td><td>true</td></tr></table></div>
</text>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-url">
<valueUri value="https://fevir.net/resources/ArtifactAssessment/179694"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-description">
<valueMarkdown
value="This example of a Comment Profile shows a comment about another Resource (Guideline Profile) in which the commenter is not the author of the Resource commented upon."/>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
<valueContactDetail>
<name value="Joanne Dehnbostel"/>
</valueContactDetail>
</extension>
<modifierExtension
url="http://hl7.org/fhir/StructureDefinition/artifact-status">
<valueCode value="active"/>
</modifierExtension>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="179694"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<title
value="Comment on Guideline: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes by Joanne Dehnbostel 2023-11-28T15:19:01.266Z"/>
<citeAsMarkdown
value="Comment on Guideline: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes by Joanne Dehnbostel 2023-11-28T15:19:01.266Z [ArtifactAssessment]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179694. Revised 2023-11-28. Available at: https://fevir.net/resources/ArtifactAssessment/179694. Computable resource at: https://fevir.net/resources/ArtifactAssessment/179694."/>
<artifactReference>🔗
<reference value="Composition/179465"/>
<type value="Composition"/>
<display
value="Guideline: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes"/>
</artifactReference>
<content>
<summary
value="It is not clear whether the reference to Asian Americans includes native Hawaiians or Pacific Islanders."/>
<freeToShare value="true"/>
</content>
</ArtifactAssessment>
IG © 2022+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot based on FHIR 5.0.0. Generated 2023-12-17
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change